We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Pharmacy (P), prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines
A guide to the legislation enabling drug services and others to supply take home naloxone without a prescription to save a life in an emergency.
As with any medicine, the MHRA will keep the safety and effectiveness of fluticasone propionate under close review.
UKHSA are providing an update to previous advice regarding contaminated non-sterile alcohol-free wipes in response to continuing detection of cases and a recent death attributable to Burkholderia stabilis infection.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Guidance for healthcare and public health commissioners on planning treatment services for dependence on prescription and over-the-counter medicines.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).